GNLX Archived Articles
Genelux Corporation (NASDAQ:GNLX): Pioneering Innovative Oncolytic Immunotherapies for Aggressive Cancers
Published on March 12, 2025
Genelux Corporation: A Promising Oncology Biotech Navigating the Challenges of Clinical Development
Published on September 24, 2024